Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Eye (Lond) ; 21(2): 191-4, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16311529

ABSTRACT

PURPOSE: To report our experience of using Aqualase technology for cataract extraction. METHODS: In total, 33 patients (20 females; mean age 71.4 years) underwent cataract surgery using Aqualase through a 3.2-mm corneal incision. Grade of nucleus, nuclear removal technique, and intraoperative complications were noted. Clinical parameters from postoperative visits were collected. RESULTS: Aqualase is capable of removing cataracts up to nuclear sclerosis 2+ (out of 4) with relative ease. Nuclei graded 2+ or greater were technically more difficult and conversion to ultrasound phacoemulsification was required in one case. Two posterior capsule ruptures occurred: one during nucleus removal (contact with the tip while aspirating without Aqualase) and one unrelated to Aqualase during aspiration of cortex. Of 25 patients seen on the first postoperative day, 22 had a clear cornea. A total of 96% patients without preoperative comorbidity achieved 6/9 or better postoperatively. One patient had transient postoperative uveitis. CONCLUSIONS: Removal of softer cataracts with Aqualase has the theoretical advantage over phacoemulsification, by carrying less risk to the posterior capsule, since the handpiece has a smooth polymer tip that has no mechanical motion inside the eye. However, the tip should not be considered entirely capsule-friendly, as rupture is possible with the foot-pedal in position two (aspiration only). Although certain adjustments to the technique are required, the method is similar enough to phacoemulsification to ensure a brief learning curve. With increasingly firm cataracts, Aqualase becomes less effective and ultrasound phacoemulsification is still superior for such cases, in our experience.


Subject(s)
Phacoemulsification/methods , Adult , Aged , Aged, 80 and over , Cataract/physiopathology , Female , Humans , Lens Nucleus, Crystalline/surgery , Male , Middle Aged , Phacoemulsification/adverse effects , Treatment Outcome , Visual Acuity/physiology
4.
Br J Ophthalmol ; 87(9): 1126-9, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12928281

ABSTRACT

BACKGROUND/AIMS: There is no effective treatment for ischaemic central retinal vein occlusion (CRVO). The two major negative outcomes are neovascular glaucoma (NVG) and severe central visual loss. In this study pars plana vitrectomy (PPV), mild panretinal photocoagulation, and intraocular gas injection were employed to prevent NVG. The potential role of incision of the lamina cribrosa (radial neurotomy) for visual recovery was examined. METHODS: Eight eyes of seven patients with ischaemic CRVO had PPV, mild panretinal photocoagulation, and intraocular perfluoropropane gas injection. Four eyes had radial neurotomies performed. The patients were examined by fundus photography, fundus fluorescein angiography, optical coherence tomography, and Goldmann visual field analysis. RESULTS: No patients suffered from neovascular glaucoma. Visual recovery was seen in patients with and without neurotomy but some patients had cataract extraction to allow visualisation for PPV. Fundus photography demonstrated reduced engorgement of retinal veins in two of the patients with neurotomy and one with PPV alone. Optical coherence tomography demonstrated macular oedema in three patients with neurotomy and all patients with PPV alone. Segmental visual field loss was seen in one patient with neurotomy suggesting damage to the optic nerve head. CONCLUSIONS: PPV is safe in ischaemic CRVO. Combined with mild PRP and intraocular gas injection the risk of neovascular glaucoma is low. Neurotomy can be added to try to improve the chances of recovery of central vision but may cause additional peripheral visual field loss.


Subject(s)
Retinal Vein Occlusion/surgery , Vitrectomy/methods , Aged , Aged, 80 and over , Fluorescein Angiography , Fluorocarbons/administration & dosage , Glaucoma, Neovascular/etiology , Glaucoma, Neovascular/prevention & control , Humans , Injections , Light Coagulation/methods , Male , Middle Aged , Pilot Projects , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Vision Disorders/etiology , Vision Disorders/prevention & control , Visual Fields
5.
J Cataract Refract Surg ; 24(3): 407-10, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9559479

ABSTRACT

PURPOSE: To investigate patient and surgeon acceptance of topical anesthesia as an alternative to peribulbar anesthesia for clear corneal phacoemulsification. SETTING: Department of Ophthalmology, Whipps Cross Hospital, London, England. METHODS: All cataract surgery was performed using a temporal clear corneal approach, bimanual phacoemulsification, and in-the-bag intraocular lens implantation. The results of 51 patients having surgery under topical anesthesia (amethocaine) were compared with those of 30 patients having peribulbar anesthesia (50:50 mixture of lignocaine 2% and bupivacaine 0.5% with hyaluronidase). No sedation was used in either group. Pain perception on administration of the anesthetic, perioperatively (period immediately surrounding and during surgery), and postoperatively was assessed using a visual analog scale from 0 to 10 (0 = no pain: 10 = worst pain imaginable). A questionnaire was used to assess the degree of patient and surgeon satisfaction. RESULTS: Administration of topical amethocaine was significantly less painful than peribulbar bupivacaine (P = .03). Perioperative pain showed a trend toward being worse in the topical anesthesia group but did not reach statistical significance. There was no difference in the postoperative pain scores of the two groups. The surgical experience was rated very satisfactory by 67% in the topical group and 73% in the peribulbar group. The surgeons reported no difficulties or complications. CONCLUSION: Topical anesthesia was safe and effective for clear corneal phacoemulsification and was well tolerated by patients. The slightly greater awareness of ocular discomfort in the topical group perioperatively did not alter patient satisfaction with the surgical experience when compared with the peribulbar group.


Subject(s)
Anesthesia, Local/methods , Anesthetics, Local/administration & dosage , Cornea/surgery , Phacoemulsification , Aged , Bupivacaine/administration & dosage , Drug Combinations , Female , Humans , Lens Implantation, Intraocular , Lidocaine/administration & dosage , Male , Orbit , Pain Measurement , Pain, Postoperative/physiopathology , Patient Satisfaction , Tetracaine/administration & dosage
6.
J Trauma ; 40(4): 640-1, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8614047

ABSTRACT

We present a case of gradual visual loss in a patient after a severe road traffic accident. The cause of visual loss was prolonged contact lens wear. We stress the importance of excluding contact lens wear and suggest a method for bedside examination of an unconscious patient to detect the presence of contact lenses.


Subject(s)
Contact Lenses/adverse effects , Unconsciousness , Vision Disorders/etiology , Adult , Humans , Male , Multiple Trauma
7.
Br J Ophthalmol ; 80(2): 148-50, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8814746

ABSTRACT

AIMS: To determine the postoperative morbidity on day 1 after uncomplicated phacoemulsification. METHODS: A prospective study was performed on 100 otherwise healthy eyes after uncomplicated phacoemulsification and lens implant. Patients were examined on the first postoperative day and any deviation from a set postoperative protocol was recorded. RESULTS: Transient intraocular pressure rises of 30 mm Hg or greater were seen in three eyes. These all settled after a single dose of oral acetazolamide 250 mg. CONCLUSIONS: The results of this study reinforce the clinical impression that the need for day 1 routine follow up in this selected group of patients is questionable and probably unnecessary.


Subject(s)
Ocular Hypertension/etiology , Phacoemulsification/adverse effects , Postoperative Care/methods , Acetazolamide/therapeutic use , Humans , Lenses, Intraocular , Ocular Hypertension/drug therapy , Prospective Studies , Visual Acuity
10.
Br J Rheumatol ; 34(11): 1092-4, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8542215

ABSTRACT

A 33-yr-old woman with systemic lupus erythematosus (SLE) and concomitant development of Brown's syndrome is described. This rare complication of SLE is discussed.


Subject(s)
Lupus Erythematosus, Systemic/complications , Ocular Motility Disorders/complications , Adult , Antibodies, Antinuclear/analysis , Eye/pathology , Female , Humans , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/immunology , Magnetic Resonance Imaging , Ocular Motility Disorders/diagnosis , Ocular Motility Disorders/pathology , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...